These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 22466)
1. [The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)]. Hata S Nihon Naibunpi Gakkai Zasshi; 1977 Oct; 53(10):1129-39. PubMed ID: 22466 [TBL] [Abstract][Full Text] [Related]
2. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)]. Stumpe KO; Vetter H; Hessenbruch V; Düsing R; Kolloch R; Krück F Klin Wochenschr; 1975 Oct; 53(19):907-11. PubMed ID: 241876 [TBL] [Abstract][Full Text] [Related]
3. Renin and beta-blockade: prorenin and aldosterone may explain the controversy. McKenna F; Davison AM Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848 [TBL] [Abstract][Full Text] [Related]
4. Effect of penbutolol on circadian blood pressure, and renin, aldosterone and cortisol levels in patients with essential hypertension. degli Uberti EC; Portaluppi F; Margutti A; Trasforini G; Bianconi M; Teodori V; Rossi R; Pansini R Acta Cardiol; 1988; 43(1):5-20. PubMed ID: 3287810 [TBL] [Abstract][Full Text] [Related]
5. Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study. Obel AO J Cardiovasc Pharmacol; 1989 Mar; 13(3):465-70. PubMed ID: 2471894 [TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics. Salvetti A; Pedrinelli R; Simonini N Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151 [TBL] [Abstract][Full Text] [Related]
7. The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents. Stokes GS; Graham RM; Weber MA Drugs; 1976; 11 SUPPL 1():150-6. PubMed ID: 6247 [TBL] [Abstract][Full Text] [Related]
8. beta-Adrenergic receptors and renin release: studies with beta-adrenoreceptor-blocking agents in the conscious rabbit. Weber MA; Oates HF; Stokes GS Clin Sci Mol Med Suppl; 1975 Jun; 2():89s-91s. PubMed ID: 28880 [TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782 [TBL] [Abstract][Full Text] [Related]
10. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension. Browne GA; Griffin TP; O'Shea PM; Dennedy MC Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. Weber MA; Stokes GS; Gain JM J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950 [TBL] [Abstract][Full Text] [Related]
13. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension. Reams GP; Bauer JH; Lau A J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665 [TBL] [Abstract][Full Text] [Related]
14. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension. Rotmensch HH; Rocci ML; Vlasses PH; Swanson BN; Fedder IL; Soyka L; Ferguson RK Am J Cardiol; 1984 Aug; 54(3):353-6. PubMed ID: 6147080 [TBL] [Abstract][Full Text] [Related]
15. Effects of carvedilol on renal function. Dupont AG Eur J Clin Pharmacol; 1990; 38 Suppl 2():S96-100. PubMed ID: 1974513 [TBL] [Abstract][Full Text] [Related]
16. The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension. Pedrinelli R; Arzilli F; Cavasinni L; Poli L; Sassano P; Salvetti A J Endocrinol Invest; 1978 Oct; 1(4):315-20. PubMed ID: 756881 [TBL] [Abstract][Full Text] [Related]
17. [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)]. Lombardo M; Fusco M; Valente D G Ital Cardiol; 1979; 9(12):1363-70. PubMed ID: 45015 [TBL] [Abstract][Full Text] [Related]
18. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients. Salvetti A; Arzilli F; Pedrinelli R; Beggi P; Motolese M Eur J Clin Pharmacol; 1982; 22(3):197-201. PubMed ID: 7049707 [TBL] [Abstract][Full Text] [Related]
19. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)]. Weidmann P; Beretta-Piccoli C; Ziegler W; Hirsch D; de Châtel RD; Reubi FC Klin Wochenschr; 1976 Aug; 54(16):765-73. PubMed ID: 8663 [TBL] [Abstract][Full Text] [Related]
20. [Clinical effect of a beta receptor blockader, oxprenolol, in hypertension--its relationship with renin-aldosterone activities]. Kunida H; Hatake S; Okamoto M Horumon To Rinsho; 1974 Sep; 22(9):1067-75. PubMed ID: 4609642 [No Abstract] [Full Text] [Related] [Next] [New Search]